Federated Hermes 13F: Adds $14M to BTSG Stake

Federated Hermes has increased its investment in BrightSpring Health Services, Inc. (NasdaqGS: BTSG) by 20.5%, according to its latest 13F filing with the SEC. The fund added 203,321 shares, bringing its total holdings to 1,195,723 shares valued at approximately $83.3 million. This filing reflects holdings as of the end of the reporting period and may not represent the investor's current position.

What Changed in Federated Hermes's BrightSpring Health Services Position

Federated Hermes grew its stake in BrightSpring Health Services by 20.5%, adding 203,321 shares to its portfolio. This brings its total holdings to 1,195,723 shares, valued at about $83.3 million.

Other Institutional Activity in BrightSpring Health Services

Several other institutional investors also adjusted their positions in BrightSpring Health Services. BlackRock, Inc. increased its holdings by 2,615,897 shares, ending with 19,602,159 shares valued at approximately $835.2 million, a 15.4% increase. Invesco Ltd. added 886,924 shares, bringing its total to 11,482,156 shares worth $489.3 million, marking an 8.4% rise. Meanwhile, Kohlberg Kravis Roberts & Co. L.P. reduced its stake by 20,117,773 shares, a 32.5% decrease, leaving it with 41,824,259 shares valued at $1.78 billion. Vanguard Portfolio Management LLC initiated a new position with 8,032,770 shares worth about $342.3 million.

BrightSpring Health Services, Inc. Stock Up 22.8%

Shares of BrightSpring Health Services traded near $69.70 on Friday. The company has a market cap of approximately $13.68 billion, with a P/E ratio of 90.52 and a forward P/E of 32.94. Its beta stands at 1.874, indicating higher volatility compared to the market. The stock's 52-week range is between $19.01 and $69.89, with a 50-day moving average of $56.66 and a 200-day moving average of $41.39. BrightSpring's liquidity is supported by a current ratio of 1.737 and a quick ratio of 1.356, while its debt-to-equity ratio is 135.679.

Recent Earnings

BrightSpring Health Services reported revenue of $13.65 billion, showing a growth of 25.6%. The company achieved an EPS of $0.77, with a net margin of 2.27% and a return on equity of 9.23%. The next earnings report is expected on July 31, 2026.

Insider Buying and Selling at BrightSpring Health Services, Inc.

Several insider transactions were reported at BrightSpring Health Services. On June 5, 2026, CEO Jon Rousseau sold 260,000 shares, while Chief of Staff and Senior Vice President Lisa Nalley sold 35,000 shares at an average price of $58.75. On June 11, 2026, Nigam Shah purchased 4,013 shares. On June 20, 2026, Scott Greenwell, President of PharMerica, sold 2,487 shares at $66.25.

Analysts Set New Price Targets

Analysts have been active in setting new price targets for BrightSpring Health Services. On June 22, 2026, BTIG maintained its 'buy' rating with a $90 price target. TD Cowen, on June 18, 2026, also maintained a 'buy' rating with an $81 target. Goldman Sachs initiated coverage with a 'buy' rating and a $71 target on June 8, 2026. The consensus among 16 analysts is a 'strong buy' with a mean target price of $66.31.

About BrightSpring Health Services

BrightSpring Health Services, Inc. is a healthcare services company based in Louisville, Kentucky. It provides home and community-based health services across the United States, focusing on pharmacy solutions and provider services. The company offers clinical and supportive care in home settings to Medicare, Medicaid, and insured populations. BrightSpring also provides a range of rehabilitation services. Founded in 1974, it employs approximately 23,500 people and is led by CEO Jon B. Rousseau.

Bottom Line

Federated Hermes's increased stake in BrightSpring Health Services suggests confidence in the company's potential. Investors keep an eye on such 13F filings to gauge institutional sentiment. As always, these filings reflect past holdings and may not indicate current positions.